Cytokinetics Cash Flow Statement (2010-2025) | CYTK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-44.60M	-58.87M	-73.36M	-25.92M	-80.60M	-13.68M	-115.25M	-134.09M	-131.43M	-129.09M	-129.40M	-134.58M	-133.34M	-142.90M	-149.73M		-155.63M	-122.59M	-178.11M	-231.87M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	5.26M	0.70M	1.20M	6.71M	9.00M	12.20M	13.20M	13.50M	15.20M	18.67M	18.72M	19.49M	21.61M	24.62M	25.36M		23.55M	27.54M	30.70M	40.70M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)			5.80M	1.29M	0.70M	-0.04M	10.00M	8.59M	0.21M	7.70M	7.60M		0.27M	0.08M	0.01M	10.42M	0.47M	0.02M	6.39M	-18.25M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)				302.10M	0.50M	0.40M	0.20M	6.15M				676.40M				6.88M				7.16M
Cash from Operations (Quarter)	-29.52M	-29.50M	-38.77M	-44.74M	-26.81M	-90.47M	-84.04M	-98.19M	-122.29M	-121.81M	-96.20M	-74.04M	-129.51M	-99.31M	-101.50M		-131.60M			-179.69M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)					1.30M	1.34M	1.97M	1.09M	6.89M	6.98M	7.08M	-13.61M	1.88M	2.66M	3.49M		3.45M			14.87M
Depreciation & Amortization (CF) (Quarter)	0.54M	0.54M	0.46M	0.73M	1.34M	1.41M	1.41M	1.66M	1.85M	1.85M	1.85M	6.33M	2.33M	2.41M	2.41M		2.30M			2.98M
Change in Working Capital
Change in Receivables (Quarter)	0.09M	-1.81M	-2.06M	51.17M	-50.76M	-4.08M	0.32M	-2.15M	0.86M	-0.02M	1.51M	-1.22M	-0.45M	-0.83M	0.24M		-14.64M			2.15M
Change in Account Payables (Quarter)	-4.05M	1.67M	-0.42M	3.86M	-3.08M	-8.85M	3.41M	13.05M	-8.11M	-4.32M	1.24M	7.71M	-10.29M	-1.81M	1.72M		-4.58M			13.05M
Change in Accured Expenses (Quarter)	-3.12M	6.15M	10.79M	1.24M	-3.52M	6.08M	8.64M	-0.35M	-7.75M	-11.43M	4.16M	32.13M	-5.58M	4.17M	5.51M		-14.37M			29.50M
Other Working Capital Changes (Quarter)	9.82M	-6.16M	7.59M	-3.86M	-0.58M	-86.42M	95.94M	-7.21M	1.63M	5.65M	-7.55M	0.27M	-1.94M	0.40M	-4.47M		0.38M			-44.75M
Investing Activities
Capital Expenditures (Quarter)	6.63M	8.79M	15.70M	-19.14M	0.94M	3.98M	-3.06M	-1.25M	0.40M	0.72M	0.22M	-1.34M		1.92M	0.70M		1.49M			0.03M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)	64.25M	-60.95M	322.86M	-322.86M	129.79M	136.03M	181.14M	157.63M	250.70M	284.44M	190.98M	-721.15M	175.30M	165.60M	170.05M		275.73M			592.70M
Cash from Investing Activities (Quarter)	-5.28M	18.88M	-208.72M	47.34M	-64.28M	65.27M	-292.37M	29.25M	165.50M	82.13M	73.04M	-81.41M	32.64M	-651.55M	-45.05M		105.96M			680.63M
Financing Activities
Other financing activities (Quarter)	4.45M				9.60M				10.52M				18.45M					0.51M	0.72M	-17.23M
Cash from Financing Activities (Quarter)	-3.60M	3.17M	300.89M	19.51M	93.85M	3.42M	389.02M	29.89M	-7.18M	5.47M	54.22M	168.80M	103.79M	821.01M	3.42M		4.75M			-403.77M
Additional items
Exchange Rate Effect (Quarter)												-0.02M	0.03M	0.02M	-0.13M		-0.27M			-0.63M
Change in Cash (Quarter)	-38.39M	-7.44M	53.41M	22.10M	2.76M	-21.79M	12.61M	-39.06M	36.03M	-34.20M	31.05M	13.33M	6.95M	70.17M	-143.25M		-21.18M			96.54M
Free Cash Flow (Quarter)	-36.15M	-38.29M	-54.47M	-25.60M	-27.75M	-94.45M	-80.98M	-96.94M	-122.69M	-122.52M	-96.42M	-72.70M	-129.51M	-101.23M	-102.20M		-133.09M			-179.72M
Net Cash Flow (Quarter)	-38.39M	-7.44M	53.41M	22.10M	2.76M	-21.79M	12.61M	-39.06M	36.03M	-34.20M	31.05M	13.35M	6.92M	70.15M	-143.13M		-20.89M			97.17M

Research Tools

Cytokinetics Cash Flow Statement (2010-2025) | CYTK

Create an account

Sign In

Reset Password